<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03325985</url>
  </required_header>
  <id_info>
    <org_study_id>17-01211</org_study_id>
    <secondary_id>R-1609-36306</secondary_id>
    <nct_id>NCT03325985</nct_id>
  </id_info>
  <brief_title>Emergency Medicine Palliative Care Access</brief_title>
  <acronym>EMPallA</acronym>
  <official_title>Emergency Medicine Palliative Care Access</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beaumont Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale New Haven Health System Center for Healthcare Solutions</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a two-arm, multi-site randomized controlled trial of 1,350 older adults (65+ years)
      with either advanced cancer (defined as metastatic solid tumor) or end-stage organ failure
      (New York Heart Association Class IV Heart Failure, End Stage Renal Disease defined as GFR &lt;
      15 ml/min/m2; or oxygen-dependent chronic obstructive pulmonary disease (COPD)) who present
      to the Emergency Department (ED), along with 675 of their informal caregivers, to compare
      nurse-led telephonic case management to facilitated, outpatient specialty palliative care.
      Investigators will compare effectiveness of two distinct palliative care models that vary by
      provider type (nurse versus physician-led) and mode of delivery (telephonic versus
      in-person): a) nurse-led telephonic case management; and b) facilitated, outpatient specialty
      palliative care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2018</start_date>
  <completion_date type="Anticipated">August 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in quality of life for patients, as measured by FACT-G</measure>
    <time_frame>Enrollment to 6 Months</time_frame>
    <description>Comparison of both interventions on quality of life in patients</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2025</enrollment>
  <condition>Advanced Cancer</condition>
  <condition>End Stage Organ Failure</condition>
  <arm_group>
    <arm_group_label>Cancer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>End-stage organ failure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nurse-led telephonic case management</intervention_name>
    <description>nurse led telephonic interviews</description>
    <arm_group_label>Cancer</arm_group_label>
    <arm_group_label>End-stage organ failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Facilitated,outpatient specialty palliative care</intervention_name>
    <description>Physician led follow up interviews</description>
    <arm_group_label>Cancer</arm_group_label>
    <arm_group_label>End-stage organ failure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients:

          -  qualifying serious, life-limiting conditions and who are scheduled for ED discharge or
             observation status will be eligible to participate.

          -  Qualifying conditions include: 1) advanced cancer (defined as a metastatic solid
             tumor); and 2) poor prognosis, end-stage organ failure (defined as New York Heart
             Association Class IV Heart Failure; End Stage Renal Disease defined as GFR &lt; 15
             ml/min/m2; or oxygen-dependent COPD).

          -  Patients who are placed in observation overnight will still be eligible to participate
             the following morning.

          -  Patients must have health insurance, reside within the geographical area, and have a
             working telephone.

        Informal Caregivers:

          -  English-speaking informal caregivers ages 18 years and older who accompany an
             eligible, enrolled patient will be eligible to participate. Informal caregivers must
             possess a working telephone.

        Exclusion Criteria:

          -  Patients who are already receiving palliative or hospice care, and those who reside in
             a skilled nursing or assisted living facility.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corita Gruzden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca Murray</last_name>
    <phone>352-265-5911</phone>
    <email>Nicole.Tang@nyumc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Murray</last_name>
      <phone>352-265-5911</phone>
      <phone_ext>31485</phone_ext>
    </contact>
    <investigator>
      <last_name>Rebecca Murray, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicole Tang</last_name>
      <phone>646-501-0565</phone>
      <email>nicole.tang@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Corita Grudzen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

